GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a remarkable shift in how we treat type 2 diabetes . These new therapies function to stimulating the body’s natural GLP-1 hormone , https://orlandonhnc972622.idblogmaker.com/40651846/glp-1-a-revolutionary-approach-in-glucose-treatment